For the non-epithelioid subgrouped patients, we found a median OS of 7.4 vs. 7.8 months, p = 0.732, for those with a low and high Ki67 tumor expression, whereas for the epithelioid patients, the median OS was 36.8 vs. 12.3 months with a low and high Ki67 tumor expression. This evidence concerns the gene MKI67 and neoplasm.